China’s State Council has announced to its people and to the world that the second largest drug market will become a world leader in pharmaceutical innovation, commercialization and manufacturing. Simply put, China will no longer rely on research-based…
China’s Regulatory Mosaic: The Troops Have Their Marching Orders

April 30, 2017 | Category: Blog | Tags: China CMO, China Drug Industry, China Fill Finish, David Deere PaizaBio, PaizaBio
China’s Drug Industry Reforms: Is the Mosaic Finally Coming Together for Western Pharma?

A note from author David Deere: To foster a global and innovative pharmaceutical industry and reduce the disproportional healthcare costs attributable to drugs, the Chinese government has formally targeted the industry for economic development. To facilitate these objectives,…
April 24, 2017 | Category: Blog | Tags: China CMO, China Consulting, China CRO, China Drug Industry, China Fill and Finish, PaizaBio
Chinese Drug Reform and the Knights Templar: Symbolism or Coincidence?

A David Deere Advisory Alert Nine centuries ago, wealthy Christians often made pilgrimages from Europe to Jerusalem, among the most sacred places in the Holy Land. It was, to say the least, an arduous and dangerous journey. In…
March 17, 2017 | Category: Blog | Tags: China CMO, China Drug Industry, China Fill/Finish, David Deere, New CFDA Policy, PaizaBio